Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LINACLOTIDE, with a corresponding US DMF Number 30266.
Remarkably, this DMF maintains an Active status since its submission on November 16, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 23, 2016, and payment made on February 23, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II